Tolemy Bio

Pre-Seed
tolemy.bio AI & Machine Learning Cambridge, United Kingdom
Total Funding $1.6M
Latest Round $1.6M Pre-Seed
Last Announced May 12, 2026
Investors Undisclosed
Decision Makers 1 Verified

About Tolemy Bio

Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Pre-Seed
Global Headquarters Cambridge, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website tolemy.bio
Domain Registered Date Mar 7, 2024

Social & Network Presence

X / Twitter Profile @TolemyBio (3 followers) Created on May 2026
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $1,643,320 · Pre-Seed

    European Biotechnology Magazine

  2. Milestone

    X account created (@TolemyBio)

    3 followers

  3. Milestone

    Website domain registered

    tolemy.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Tolemy Bio.

Funding History

1 Round
Pre-Seed · May 12, 2026

Founders & Leadership

2

Alex Ward

Co-founder & CEO

Work email & phone locked Unlock →

Caelan Anderson

Co-founder & CTO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts